Abstract
This review addresses the cardiovascular, cerebrovascular, and metabolic consequences that accompany obstructive sleep apnea-hypopnea (OSAH) in conjunction with the mechanistic pathways implicated in mediating these effects. Particular emphasis is placed on the association with hypertension (HTN). Varying levels of evidence support a role of OSAH in perpetuating sustained HTN, nocturnal HTN, and difficult to control HTN as well as in contributing to the occurrences of nondipping of blood pressure (BP) and increased BP variability. In this context, the emergence of matched designs, adjusted analyses, meta-analyses as well as longitudinal and interventional studies strengthens causal inferences drawn from older observational studies, which suffered from such limitations as confounding. © 2009 American Journal of Hypertension, Ltd.
Cite
CITATION STYLE
Friedman, O., & Logan, A. G. (2009, May). The price of obstructive sleep apnea-hypopnea: Hypertension and other ill effects. American Journal of Hypertension. https://doi.org/10.1038/ajh.2009.43
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.